Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $103,115 - $134,550
2,600 New
2,600 $134,000
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $9,596 - $10,880
200 New
200 $10,000
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $590,520 - $770,280
-12,000 Reduced 80.0%
3,000 $14,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $125,874 - $137,235
2,100 Added 16.28%
15,000 $2,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $463,932 - $535,416
8,400 Added 186.67%
12,900 $50,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,500
4,500 $13,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.